Skip to main content

Advertisement

Log in

Long-term results of the safety and effectiveness of a novel microshunt in Japanese patients with primary open-angle glaucoma

  • Clinical Investigation
  • Published:
Japanese Journal of Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To evaluate the long-term safety and effectiveness of the Preserflo MicroShunt in Japanese primary open-angle glaucoma (POAG) patients.

Study design

Single-site, nonrandomized observational study.

Patients and methods

Eight eyes of 7 POAG patients were included. The surgical complications and interventions were monitored. The preoperative and postoperative intraocular pressures (IOPs), numbers of antiglaucoma medications, logarithm of the minimum angle of resolution visual acuity (VA), mean deviation (MD) slope, and corneal endothelial cell density (CECD) were compared retrospectively.

Results

The mean follow-up period was 68.9 months (range, 48–76 months). The baseline IOP of 17.9 ± 3.5 mmHg and the number of glaucoma medications of 3.5 ± 0.5 were significantly reduced at subsequent follow-up visits. At 1, 2, 3, 4, 5, and 6 years postoperatively, the IOPs were 13.8 ± 2.9, 12.8 ± 2.3, 12.1 ± 3.2, 12.6 ± 2.5, 12.3 ± 1.0, and 13.5 ± 3.1 mmHg, respectively, with the use of 1.6 ± 1.4, 1.6 ± 1.6, 1.5 ± 1.4, 1.5 ± 1.4, 1.9 ± 1.3, and 2.0 ± 1.1 medications. Postoperative transient hyphema occurred in 1 eye. Postoperative needling was required in 5 eyes, 12 times in total. No eyes showed significant VA decline, except for 1 eye with a severe central visual field defect that existed preoperatively. The preoperative MD slope of − 1.6 ± 1.2 dB/year improved significantly, to − 0.3 ± 0.2 dB/year (P = 0.023), postoperatively. The baseline CECD decreased from 2595 ± 292 to 2478.4 ± 255 postoperatively.

Conclusion

The microshunt surgical procedure is safe and effective for Japanese POAG patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Group CN-TGS. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol. 1998;126:487–97.

    Article  Google Scholar 

  2. A Investigators. The advanced glaucoma intervention study (AGIS): 7 the relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol. 2000;130:429–40.

    Article  Google Scholar 

  3. Garway-Heath DF, Crabb DP, Bunce C, Lascaratos G, Amalfitano F, Anand N, et al. Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial. Lancet. 2015;385:1295–304.

    Article  CAS  Google Scholar 

  4. Kashiwagi K, Kogure S, Mabuchi F, Chiba T, Yamamoto T, Kuwayama Y, et al. Change in visual acuity and associated risk factors after trabeculectomy with adjunctive mitomycin C. Acta Ophthalmol (Copenh). 2016;94:e561–70.

    Article  CAS  Google Scholar 

  5. Kirwan JF, Lockwood AJ, Shah P, Macleod A, Broadway DC, Kinget AJ, et al. Trabeculectomy in the 21st century: a multicenter analysis. Ophthalmology. 2013;120:2532–9.

    Article  Google Scholar 

  6. Razeghinejad MR, Havens SJ, Katz LJ. Trabeculectomy bleb-associated infections. Surv Ophthalmol. 2017;62:591–610.

    Article  Google Scholar 

  7. Gedde SJ, Herndon LW, Brandt JD, Budenz DL, Feuer WJ, Schiffman JC, et al. Postoperative complications in the tube versus trabeculectomy (TVT) study during five years of follow-up. Am J Ophthalmol. 2012;153:804–14.

    Article  Google Scholar 

  8. Saheb H, Ahmed IIK. Micro-invasive glaucoma surgery: current perspectives and future directions. Curr Opin Ophthalmol. 2012;23:96–104.

    Article  Google Scholar 

  9. Ittoop SM, Kahook MY, Seibold LK. Trabecular meshwork bypasses. In: Kahook MY, editor. MIGS: advances in glaucoma surgery. West Deptford: Slack Incorporated; 2014. p. 27–55.

    Google Scholar 

  10. Beckers HJ, Kinders KC, Webers CA. Five-year results of trabeculectomy with mitomycin C. Graefes Arch Clin Exp Ophthalmol. 2003;241:106–10.

    Article  CAS  Google Scholar 

  11. Batlle JF, Fantes F, Riss I, Pinchuk L, Alburquerque R, Kato YP, et al. Three-year follow-up of a novel aqueous humor microshunt. J Glaucoma. 2016;25:e58-65.

    Article  Google Scholar 

  12. Pinchuk L, Wilson GJ, Barry JJ, Schoephoerster RT, Parel J-M, Kennedy JP. Medical applications of poly (styrene-block-isobutylene-block-styrene)(“SIBS”). Biomaterials. 2008;29:448–60.

    Article  CAS  Google Scholar 

  13. Acosta AC, Espana EM, Yamamoto H, Davis S, Pinchuk L, Weber BA, et al. A newly designed glaucoma drainage implant made of poly (styrene-b-isobutylene-b-styrene): biocompatibility and function in normal rabbit eyes. Arch Ophthalmol. 2006;124:1742–9.

    Article  CAS  Google Scholar 

  14. Pinchuk L, Riss I, Batlle JF, Kato YP, Martin JB, Arrieta E, et al. The development of a micro-shunt made from poly (styrene-block-isobutylene-block-styrene) to treat glaucoma. J Biomed Mater Res B Appl Biomater. 2017;105:211–21.

    Article  CAS  Google Scholar 

  15. Schlenker MB, Durr GM, Michaelov E, Ahmed IIK. Intermediate outcomes of a novel standalone ab externo SIBS Microshunt with mitomycin C. Am J Ophthalmol. 2020;215:141–53.

    Article  CAS  Google Scholar 

  16. Honjo M, Sakata R, Fujishiro T, Shirato S, Aihara M. One-year postoperative outcomes of filtration minimally invasive glaucoma surgery using the PRESERFLO MicroShunt for primary open angle glaucoma in Japanese patients. Nippon Ganka Gakkai Zasshi. 2020;124:705–12 (in Japanese).

    Google Scholar 

  17. Batlle JF, Corona A, Albuquerque R. Long-term results of the PRESERFLO MicroShunt in patients with primary open-angle glaucoma from a single-center nonrandomized study. J Glaucoma. 2021;30:281–6.

    Article  Google Scholar 

  18. Rao HL, Addepalli UK, Jonnadula GB, Kumbar T, Senthil S, Garudadri CS. Relationship between intraocular pressure and rate of visual field progression in treated glaucoma. J Glaucoma. 2013;22:719–24.

    Article  Google Scholar 

  19. Sakata R, Yoshitomi T, Iwase A, Matsumoto C, Higashide T, Shirakashi M, et al. Factors associated with progression of Japanese open-angle glaucoma with lower normal intraocular pressure. Ophthalmology. 2019;126:1107–16.

    Article  Google Scholar 

  20. Fujita A, Sakata R, Ueda K, Nakajima K, Fujishiro T, Honjo M, et al. Evaluation of fornix-based trabeculectomy outcomes in Japanese glaucoma patients based on concrete long-term preoperative data. Jpn J Ophthalmol. 2021;65:306–12.

    Article  CAS  Google Scholar 

  21. Costa VP, Spaeth GL, Eiferman RA, Orengo-Nania S. Wound healing modulation in glaucoma filtration surgery. Ophthalmic Surg Lasers Imaging Retina. 1993;24:152–70.

    Article  CAS  Google Scholar 

  22. Costa VP, Moster MR, Wilson RP, Schmidt CM, Gandham S, Smith M. Effects of topical mitomycin C on primary trabeculectomies and combined procedures. Br J Ophthalmol. 1993;77:693–7.

    Article  CAS  Google Scholar 

  23. Seol BR, Lee SY, Kim YJ, Kim YK, Jeoung JW, Park KH. Comparison of the efficacy and safety of trabeculectomy with mitomycin C according to concentration: a prospective randomized clinical trial. J Clin Med. 2021;10:59.

    Article  CAS  Google Scholar 

  24. Lenzhofer M, Kersten-Gomez I, Sheybani A, Gulamhusein H, Strohmaier C, Hohensinn M, et al. Four-year results of a minimally invasive transscleral glaucoma gel stent implantation in a prospective multi-centre study. Clin Experiment Ophthalmol. 2019;47:581–7.

    Article  Google Scholar 

  25. Schargus M, Busch C, Rehak M, Meng J, Schmidt M, Bormann C, et al. Functional monitoring after trabeculectomy or XEN Microstent implantation using spectral domain optical coherence tomography and visual field indices: a retrospective comparative cohort study. Biology (Basel). 2021;10:273.

    Google Scholar 

Download references

Acknowledgements

This work was supported by the Japan Society for the Promotion of Science (JSPS), grant number 19K09965 (to M.H.) and Kakenhi grant number 20H03839 (to M.A.). The sponsor or funding organization had no role in the design of this research nor in how the research was conducted. The Preserflo MicroShunt was provided without financial compensation by InnFocus MicroShunt (Santen).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Makoto Aihara.

Ethics declarations

Conflicts of interest

T. Ahmed, None; M. Honjo, None; R. Sakata, None; T. Fujishiro, None; S. Shirato, None; M. Aihara, None.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Corresponding Author: Makoto Aihara

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ahmed, T., Honjo, M., Sakata, R. et al. Long-term results of the safety and effectiveness of a novel microshunt in Japanese patients with primary open-angle glaucoma. Jpn J Ophthalmol 66, 33–40 (2022). https://doi.org/10.1007/s10384-021-00893-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10384-021-00893-x

Keywords

Navigation